Canadian Markets for Peripheral Vascular Devices 2011

Millennium Research Group
December 29, 2010
SKU: MIL6661455
License type:
Countries covered: Canada

Introduction:

Through 2015, the Canadian peripheral vascular (PV) device market will grow steadily as a result of increased adoption of minimally invasive treatment options for peripheral vascular disease (PVD) and new device technologies that encourage physician adoption of PV devices in a greater patient population. Clinical trials will become increasingly important as manufacturers seek vascular-indication approval for their devices and Canadian physicians continue to act conservatively until conclusive clinical evidence for a device is available. The advancement of the practice of interventional radiology in Canada, through increased recognition among physicians and more training in interventional radiology techniques, will also contribute significantly to the PV device market as these physicians are trained in several PV procedures. The limited budgets of Canadian hospitals will curb potential revenues due to demand for lower-priced devices. Nevertheless, growing awareness of PVD and physician interest in treating the disease will spur considerable market growth through 2015, generating revenues of over $70 million.

Questions Answered in This Report:
  • The Canadian health care system is under strong pressure to contain costs in terms of health care expenditures. How do these cost-containment efforts affect revenue growth? What is the impact on average selling prices (ASPs)?
  • The highly anticipated CREST (Carotid Revascularization Endarterectomy Versus Stenting) trial released preliminary data in early 2010. How has this data been received by the physicians in Canada? What impact will this have on the carotid stent and embolic protection device (EPD) markets?
  • Thoracic aortic stent grafts have been a key area of innovation for device manufacturers due to their rapid adoption of this technology. How will newer technologies expand the treatable patient population and contribute to market growth? What is the rate of adoption of these devices, and how will this impact the market?
  • Canadian physicians tend to be more conservative in the adoption of new technologies compared to their US counterparts. How will physician tendencies affect their acceptance and interpretation of clinical trial results? What effect will they have on the adoption of innovative products?
  • PTA balloon catheters are commonly used during plain old balloon angioplasties (POBAs) in Canada. How will the PTA balloon catheter market be impacted by growth in PV stenting? Which indications will increase the most rapidly and why? What changes will occur in the breakdown between PTA-with-stent procedures and POBAs?
Scope:

Regions covered: Canada


Procedure segmentation: Our analysis uses the following breakdown of procedures:
  • PV stent procedures
  • By indication (carotid, renal, iliac, femoropopliteal [fem-pop], and infrapopliteal [infrapop])
  • PTA balloon catheter procedures
  • By indication (carotid, renal, iliac, fem-pop, infrapop, and arteriovenous [AV] access)
  • Embolic protection device (EPD) procedures
  • By indication (carotid and renal)
  • Inferior vena cava filter (IVCF) placements
  • By device type (permanent and retrievable)
  • Aortic stent graft procedures
  • By indication (abdominal and thoracic)
  • Synthetic surgical graft procedures
  • By indication (abdominal aortic, thoracic aortic, peripheral bypass [above-the-knee (ATK) and below-the-knee (BTK)], AV access, and extra-anatomical [XA])
  • PV accessory device procedures
  • By type (diagnostic-only and interventional)
Market segmentation: Our analysis uses the following breakdown of the market:
  • PV stents
  • By indication (carotid, renal, iliac, fem-pop, and infrapop)
  • By stent type (balloon-expandable, self-expandable, and covered)
  • PTA balloon catheters
  • By device type (standard, small, large, and other [high pressure and specialty])
  • EPDs
  • By indication (carotid and renal)
  • IVCFs
  • By device type (permanent and retrievable)
  • Aortic stent grafts
  • By indication (abdominal and thoracic)
  • Synthetic surgical grafts
  • By indication (abdominal aortic, thoracic aortic, peripheral bypass [ATK and BTK], AV access, and XA)
  • By graft material (Dacron and expanded polytetrafluoroethylene [ePTFE])
  • PV accessory devices
  • By device type (guidewires, diagnostic catheters, sheaths, and guiding catheters)
Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2009-2015).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.


More Canada Stents Reports

Canada Peripheral Vascular Devices - Market Trend Till 2016 by ABMRG
This market report provides vital market data on the peripheral vascular devices. The report also provides historic and forecasted market size in terms of value ($mn), ...

See all reports like this >>

More Canada Reports

D&B Country RiskLine Report: Canada by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Canada by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Canada: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Canada, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

2007 Canada Industry & Market Outlook report by Barnes Reports
The 2007 Canada Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Canada and 500+ minor industries ...

The 2005 Canada Economic and Product Market Databook by Icon Group International, Inc.
Market Potential Estimation Methodology Overview This study covers the outlook products in Canada. For the year reported, estimates are given for the latent demand, or ...

See all reports like this >>